Shilanski & Associates’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-8,638
Closed -$931K 116
2021
Q1
$931K Sell
8,638
-139
-2% -$15.4K 0.5% 59
2020
Q4
$1.03M Buy
8,777
+80
+0.9% +$8.15K 0.63% 50
2020
Q3
$745K Sell
8,697
-1
-0% -$85 0.5% 57
2020
Q2
$688K Buy
+8,698
New +$679K 0.5% 56

Other funds holding DVA

Shilanski & Associates's DVA Position: Q2 2021 in Review

Shilanski & Associates sold out of DaVita (DVA) in Q2 2021, closing a stake of 8,638 shares — an estimated $931K sold.

Shilanski & Associates first reported a position in DVA in Q2 2020 and held it in 4 quarters. The position peaked at $1.03M in Q4 2020. 515 funds tracked by Wall St. Rank hold DVA as of Q2 2021.

  • Shilanski & Associates reported no remaining DaVita position as of Q2 2021 after selling out during the quarter.
  • Shilanski & Associates sold 8,638 DaVita shares in Q2 2021, an estimated $931K.
  • Shilanski & Associates first reported a position in DaVita in Q2 2020 and held it in 4 quarters.
  • Shilanski & Associates's DaVita position peaked at $1.03M in Q4 2020.
  • 515 funds tracked by Wall St. Rank held DaVita as of Q2 2021.

Based on Shilanski & Associates's 13F filing for Q2 2021, filed 13 Aug 2021.